Choroideremia gene therapy

· University of Oxford

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Choroideremia gene therapy, covering 2017-11-17 to 2017-11-17. Get the full timeline:

Most recent: Clinical Trial Update: Gene Therapy for Blindness Caused by Choroideremia [Phase 1, Phase 2]